Navigation Links
ATS Medical Announces Canadian Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve
Date:6/23/2008

MINNEAPOLIS, June 23 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced Health Canada -- Medical Device Bureau, Therapeutic Products Programme has approved use of the ATS Open Pivot(R) AP360(TM) Mechanical Heart Valve.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO )

The ATS AP360 heart valve maximizes hemodynamic performance with a new supra-annular cuff design that facilitates implantation. The original ATS Medical Open Pivot(R) Heart Valve is highly regarded for fundamental design features that promote best-in-class hemodynamic performance, enhanced resistance to blood clot formation and improved patient quality of life through quieter valve operation. In a response to the highly individualized and specific valve selection criteria of cardiac surgeons, particularly with respect to implantability, the ATS AP360 combines proven performance with a cuff design that extends its appeal to a broader spectrum of surgeons.

About ATS Medical

ATS Medical, Inc. provides innovative products and services focused on cardiac surgery. The Company, global in scope, is headquartered in Minneapolis, Minnesota. More than 145,000 ATS Open Pivot(R) Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3f(R) brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medica
'/>"/>

SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. 17th Annual Congress on Womens Health To Be Held March 27-29, 2009 in Collaboration with American Medical Womens Association (AMWA)
2. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
3. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
4. BioMS Medical to present at Jefferies Healthcare Conference
5. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
6. Medicare Exemplary Provider Accreditation Awarded to Regenesis Biomedical
7. A Perfect Storm Threatens Patient Access to Specialty Medical Care
8. HIPAA Privacy Rule Impedes Biomedical Research
9. NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
10. PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress
11. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Mo. From cell phones to cars and ... life. Scientists and technology companies constantly are seeking ... for the first time using a water-based solution, ... a long-lasting and more efficient nuclear battery that ... a reliable energy source in automobiles and also ...
(Date:9/16/2014)... BlueInGreen® , a water quality company ... dissolved gases into liquids, announced the addition of ... representative firm to its sales network. H2Flow will ... and wastewater applications in the Canadian provinces of ... 1992 and serves Quebec and Ontario markets for ...
(Date:9/16/2014)... Fresne, President and CEO of Egenix, Inc. is pleased to ... its Scientific Advisory Committee. Dr. Vagner, a graduate ... performed research at Embl (European Molecular Biology Laboratory) Heidelberg, ... of health and medical research. He is a Research Director ... France , and at the Gustave Roussy ...
(Date:9/16/2014)... 16, 2014  The Council for Entrepreneurial Development ... in the country, today released a mid-year update ... It showed that in the first ... startups in the technology, life science, advanced ... from a variety of sources. Significant investment in technology ...
Breaking Biology Technology:BlueInGreen® Expands into Canada – Signs Representative Agreement with H2Flow Equipment Inc. 2New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 3CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 4
... Oct. 19 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... global biopharmaceutical company focused on endocrine therapy and ... intended to complete the clinical development of the ... macimorelin (AEZS-130) which could be the first oral ...
... Calif., Oct. 18 /PRNewswire / -- ... of human induced pluripotent stem cells (iPSCs) using a ... and efficiency of reprogramming. The discoveries, which were ... between Fate Therapeutics and The Scripps Research Institute (TSRI), ...
... Oct. 16 Summerhill Biomass Systems is planting the seeds ... named after the Cayuga County community where the technology was ... for grinding up timber, brush, corn stalks and other plant ... James T. McKnight, Summerhill president and co-founder, said he,s eager ...
Cached Biology Technology:AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency 3Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 2Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 3Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo 2Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo 3
(Date:9/16/2014)... -- Valencell, Inc., a leader in performance biometric data sensor ... Companies" representing North Carolina,s hottest ... Conference on September 16-17 th at the ... Raleigh, North Carolina . Valencell,s President Dr. ... "Digital Health Spotlight Sector" on how the Company,s internationally ...
(Date:9/16/2014)... , Sept. 16, 2014 As open enrollment ... important decisions about their 2015 benefits. According to ... solutions business of Aon plc (NYSE: ... a more proactive role in managing their health care ... ever for individuals to understand how they can make ...
(Date:9/15/2014)... and gut microbes influence processes from digestion to disease ... most biodiverse terrestrial ecosystems on the planet, more is ... the tropics. Smithsonian scientists and colleagues working on Panama,s ... a single tree were home to more than 400 ... tree species contained more than 7,000 different kinds. , ...
Breaking Biology News(10 mins):Valencell, Inc. Selected as 'Showcase Company' at CED Tech Venture Conference 2014 2Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 2Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 3Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 4Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 5Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 6Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 7Smithsonian scientists discover tropical tree microbiome in Panama 2
... published today in Biology Letters found that ship ... found little evidence that crabs acclimatise to noise over time. ... found that crabs exposed to recordings of ship noise showed ... real world this could have implications for growth and, if ...
... demographics likely put you at risk for salt-sensitive hypertension, ... you. The concept is that free radicals in ... rather than eliminate excess through urination. Excess sodium, in ... hypertension researcher in the Section of Experimental Medicine at ...
... March 2013 issue of The Journal of Urology , ... study conducted by four physicians from Radiotherapy Clinics of ... study, 25 Year Disease Free Survival Rate after Irradiation ... of Recurrence Used for Radical Prostatectomy, is the first-ever ...
Cached Biology News:Ship noise makes crabs get crabby 2Sodium transporter appears likely target for treating salt-sensitive hypertension 2Georgia Physicians' Study Published in The Journal of Urology 2Georgia Physicians' Study Published in The Journal of Urology 3Georgia Physicians' Study Published in The Journal of Urology 4
...
... new Class II safety cabinets Heraeus HERAsafe KS ... user-orientated design. ,The new frameless slanted window ... area. The new front window design makes it ... large work aperture with a height of more ...
... has recently launched a custom synthesis ... (siRNA). Thermos siRNA molecules are: ... 2 DNA bases overhang at the ... Delivered fully deprotected and ready-to-use. ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
Biology Products: